Please assess the completion status of the following clinical trial:

Trial Title: Assessment of Blood Loss With a Point Of Care Device

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* ≥18 years~* Patient in antiplatelet monotherapy (aspirin or clopidogrel) or dual therapy (aspirin + clopidogrel / prasugrel / ticagrelor) in the context of secondary prevention after:~  * acute coronary syndrome~ * and / or intracoronary stenting~* Planned or urgent hip (gamma nail, total prosthesis or through DHS) or knee arthroplasty~* Informed consent of the participant~* Patient receiving a social security scheme or entitled~Exclusion Criteria:~* Polytrauma~* Anemia \<9g/dL~* Indication for oral anticoagulation~* Pelvic fracture justifying complex surgery~* Ongoing or recent major bleeding or recent major surgery (\< 3 weeks)~* Liver failure~* Thrombopenia \<80 000/µl~* Lack of health insurance~* Mental disability~* Participation to any other research protocol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Planned hip or knee arthroplasty (Type: None): Patients with planned hip or knee arthroplasty
- urgent hip or knee arthroplasty (Type: None): Patients with hip or knee arthroplasty in emergency.

Based on this trial design, predict the completion outcome and termination type (if applicable).